asiaticoside has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, H; Qiu, J; Wang, D; Wang, X; Wu, Q; Xia, C; Yu, L; Zhang, X | 1 |
| Qin, DL; Wan, JY; Wu, K; Xiao, SH; Zhang, Z; Zhou, QX | 1 |
2 other study(ies) available for asiaticoside and Lung Injury, Acute
| Article | Year |
|---|---|
Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Disease Models, Animal; Down-Regulation; Lipopolysaccharides; Macrophages; Male; Mice, Inbred BALB C; Signal Transduction; Transcription Factor RelA; Triterpenes | 2015 |
[Effects of asiaticoside on the balance of inflammatory factors of mouse's acute lung injury induced by LPS].
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Centella; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Interleukin-10; Interleukin-6; Interleukins; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Random Allocation; Triterpenes; Tumor Necrosis Factor-alpha | 2008 |